In vitro demonstration of a potential role for STING agonist in HIV cure

• A. Koblansky,
• S. Raines,
• J. Schawalder,
• D. Irlbeck,
• C. Galardi,
• J. Brehm,
• J. Ramanjulu,
• D. Margolis,
• H. Madsen

Affiliations

A. Koblansky

ViiV Healthcare, Chapel Hill, USA; UNC HIV Cure Center, Chapel Hill, USA

S. Raines

UNC HIV Cure Center, Chapel Hill, USA

J. Schawalder

ViiV Healthcare, Chapel Hill, USA

D. Irlbeck

ViiV Healthcare, Chapel Hill, USA

C. Galardi

ViiV Healthcare, Chapel Hill, USA

J. Brehm

ViiV Healthcare, Chapel Hill, USA

J. Ramanjulu

GlaxoSmithKline, Upper Providence, USA

D. Margolis

UNC HIV Cure Center, Chapel Hill, USA

H. Madsen

ViiV Healthcare, Chapel Hill, USA